Condiciones de salud que arándano puede ayudar a apoyar.
Blueberries contain abundant anthocyanins and polyphenols that support antioxidant defense through both direct free-radical scavenging and indirect upregulation of endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase) via the Nrf2/ARE pathway. Human studies confirm that blueberry anthocyanins are absorbed intact into the bloodstream, where their appearance correlates with increased serum antioxidant capacity. Clinical trials in at-risk populations (postmenopausal women, smokers, men with metabolic syndrome) show reductions in oxidative DNA damage and lipid hydroperoxides, though effects on enzymatic antioxidant markers are mixed. The evidence base is growing but heterogeneous, and further well-controlled RCTs are needed.
Blueberries (rich in anthocyanins and pterostilbene) improve endothelial function, reduce arterial stiffness, and lower blood pressure in RCTs. Meta-analyses confirm blueberry consumption reduces systolic BP by ~3–4 mmHg. Anthocyanins from blueberries upregulate eNOS, inhibit LDL oxidation, and reduce arterial inflammation.
Evidence from multiple RCTs and a major 2026 review of 12 clinical trials supports blood pressure reductions with blueberry intake, particularly in individuals with elevated cardiometabolic risk. However, results are inconsistent across trials, and some well-designed studies using 24-hour ambulatory monitoring showed no significant effect.
Multiple RCTs and meta-analyses show blueberry consumption can reduce fasting blood glucose and HbA1c, particularly in individuals with diabetes or prediabetes. Effects on insulin sensitivity are promising but inconsistent across trials. Anthocyanins appear to modulate glucose metabolism via gut-hormone and pancreatic pathways.
Small RCTs and observational cohorts link higher anthocyanin and blueberry intake with greater bone mineral density (BMD). A crossover RCT in postmenopausal women found freeze-dried blueberry increased net bone calcium retention versus no treatment.
Clinical evidence shows blueberry supplementation improves psychomotor speed, delayed recall, and processing speed in older adults and MCI populations—domains commonly impaired in brain fog. Cerebral blood flow improvements measured via fMRI provide objective mechanistic support.
Several RCTs report significant reductions in total and LDL cholesterol with blueberry intake, though pooled meta-analytic evidence is heterogeneous. Effects appear more consistent in at-risk populations consuming blueberry for ≥6 weeks.
Clinical and preclinical evidence shows blueberry polyphenols suppress inflammatory cytokines including TNF-α, IL-6, and CRP, primarily via NF-κB pathway inhibition. Human RCT data in metabolic syndrome subjects support reductions in circulating inflammatory markers with blueberry intake.
Human RCT evidence indicates blueberry consumption improves endothelial function (flow-mediated dilation) in healthy and at-risk populations, with consistent support across multiple trials. Effects on arterial stiffness exist but are less certain. Mechanistically, improved nitric oxide bioavailability via eNOS activation is the primary pathway.
Blueberries have meaningful human clinical evidence supporting their role in attenuating cognitive decline and supporting healthy brain aging, primarily driven by their high anthocyanin content. Multiple randomized controlled trials (RCTs) in older adults with mild cognitive impairment (MCI) or subjective cognitive decline have shown improvements in episodic memory, processing speed, and executive function. A 2025 meta-analysis of nine RCTs found a statistically significant improvement in episodic memory (SMD = 0.34) in elderly individuals with MCI or subjective cognitive decline. Epidemiological data further support these findings, with large longitudinal studies associating greater blueberry intake with slower rates of cognitive aging.
Blueberry intervention studies in children (aged 7–10) and older adults show improvements in executive function, reaction times, and psychomotor function, which are components of focused attention and concentration. A 2019 systematic review of 11 clinical trials confirmed these domains.
A large prospective cohort study (36,000+ women) investigated blueberry and anthocyanin intake in relation to cataract and age-related macular degeneration (AMD) risk. Preclinical and mechanistic evidence supports anthocyanins' role in retinal protection via antioxidant pathways.
Blueberry polyphenols act as prebiotics, altering gut microbial composition and supporting growth of short-chain fatty acid-producing bacteria. Human RCT data confirm microbiome compositional changes, and gut-derived phenolic metabolites are established mediators of blueberry's systemic cardiometabolic effects.
Blueberries are among the richest dietary sources of anthocyanins and polyphenols with documented anti-aging effects including reduced oxidative DNA damage, improved cognitive aging, and reduced vascular aging biomarkers. Multiple RCTs in older adults demonstrate blueberry supplementation improves memory, executive function, and cardiovascular risk markers.
Epidemiological and clinical evidence links regular anthocyanin-rich blueberry intake with reduced cardiovascular disease risk factors, including improvements in lipids and endothelial function. RCT data on individual CVD biomarkers are mixed but directionally favorable in at-risk populations.
A key RCT using a gold-standard hyperinsulinemic-euglycemic clamp demonstrated significant improvement in whole-body insulin sensitivity in obese, insulin-resistant adults given blueberry bioactives for 6 weeks. Subsequent larger trials have shown inconsistent results.
Blueberries are rich in anthocyanins (primarily delphinidins and cyanidins) with documented anti-VEGF, antioxidant, and anti-inflammatory effects on retinal tissue. A 2024 PMC review of berries and AMD confirmed that blueberry extracts reduce oxidative stress and inflammation in retinal models and emerging clinical evidence indicates dietary intake of blueberry anthocyanins may enhance visual function and slow AMD progression.
Multiple RCTs show blueberry supplementation improves delayed memory and paired associate learning in older adults and those with mild cognitive impairment. A 2019 systematic review of 11 clinical studies confirmed cognitive benefits, particularly for delayed memory and executive function.
Multiple RCTs specifically conducted in metabolic syndrome populations show blueberries reduce inflammatory markers, improve endothelial function, and modestly improve some glycemic and lipid parameters. A systematic review found six human intervention trials using blueberry in MetS subjects.
A New Zealand RCT found that blueberry smoothie consumption before and after eccentric exercise significantly accelerated recovery of peak isometric muscle strength at 60 hours post-exercise. Evidence for reducing muscle soreness is mixed across other trials.
Brain imaging studies in humans show blueberry supplementation increases cerebral blood flow and activates brain regions associated with cognitive function and plasticity. Anthocyanins enhance neuronal signaling pathways including BDNF and CREB associated with synaptic plasticity.
Blueberry polyphenols increase nitric oxide bioavailability in human endothelial cells and in vivo by activating eNOS, reducing NADPH oxidase activity, and decreasing superoxide-mediated NO quenching. Plasma nitrite (NO2−) increases have been measured in human RCTs after blueberry consumption.
Blueberry anthocyanins and vitamin C support collagen synthesis and protect skin from oxidative degradation. In vitro and early human skin sample studies show anthocyanin application reduces collagen breakdown. Direct RCT evidence in humans for oral blueberry supplementation on wrinkles is limited.
An 8-week RCT in type 2 diabetes men found significantly lower triglycerides with 22 g/day freeze-dried blueberries versus placebo. Pooled meta-analytic evidence shows a directionally favorable but non-significant reduction across broader populations.
Blueberry anthocyanins have demonstrated in vitro antibacterial activity against urinary tract infection pathogens including E. coli, K. pneumoniae, and P. aeruginosa. Human clinical evidence for UTI prevention specifically from blueberry (distinct from cranberry) remains limited.
Blueberry anthocyanins inhibit urinary tract pathogens in vitro and share biological mechanisms with cranberry for anti-adhesion activity. Human RCT evidence specifically for blueberry in UTI prevention is lacking, though the mechanistic basis is established.
Volver